Citagrel Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate
Prescription medication
Seas Pharmaceutical Co., Ltd.
MFDS item code 201803665 · Approved 2018.09.10
This product's status changed to Expired on 2023.09.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of blood clots in atrial fibrillation
This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It is also effective in alleviating atherosclerotic symptoms such as cardiovascular-related death, myocardial infarction, and stroke in patients with acute coronary syndrome, including unstable angina or non-Q-wave myocardial infarction. It is effective for patients who have undergone or are scheduled for coronary intervention or coronary artery bypass grafting. This medication is used to reduce the risk of thromboembolism and stroke in patients with atrial fibrillation who cannot use vitamin K antagonists. It is particularly suitable when the risk of bleeding is low and is helpful for patients with vascular risk factors. Overall, this medication plays a vital role in preventing and improving vascular-related risks and complications.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this medicine is initiated, start with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer this medicine 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This medicine may be administered with or without food.
This medication prevents platelet aggregation in the blood and prevents clot formation. This drug must be converted to its active form in the liver to be effective, therefore, individuals with genetically impaired enzymes that metabolize this drug may experience reduced efficacy. Additionally, taking this medication with certain drugs may increase the concentration of its active metabolite and raise the risk of bleeding, thus, co-administration with such drugs is not recommended. This medication should not be taken if you are allergic to it or its ingredients, currently have bleeding, or have severe liver damage. Pregnant or nursing women should consult a doctor before using this medication. Due to bleeding risks, any symptoms of bleeding should be reported to healthcare professionals immediately, and the doctor should be informed prior to any scheduled surgery regarding the use of this medication. Caution is necessary when taking this medication with other drugs that elevate bleeding risks, especially aspirin or anticoagulants, as this can increase the risk of bleeding. Regular monitoring should be performed for any symptoms of bleeding or blood abnormalities during the use of this medication. Elderly patients, those with reduced kidney or liver function, and individuals with low body weight should use this medication with heightened caution due to increased bleeding risk. Overdosage may prolong bleeding time, and since there is no specific antidote, it should be avoided. This medication should be kept out of reach of children and should not be transferred to another container.
Hemorrhage, gastrointestinal bleeding, hemorrhage requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial hemorrhage, significant hemorrhage, life-threatening hemorrhage, fatal hemorrhage, hemorrhagic stroke, need for anticoagulant usage, need for blood transfusion, thrombocytopenia, neutropenia, aplastic anemia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, headache, dizziness, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, decreased motor function, tremor, speech disturbance, abnormal gait, hyperkinesia, ataxia, sensory disturbances, constipation, nausea, vomiting, hiccups, dry mouth, dysphagia, tongue disorders, insomnia, depression, forgetfulness, anxiety, confusion, abnormal thoughts, abnormal behavior, rigidity, facial edema, syncope, purpura, hematochezia, thrombocytopenia, anemia, cerebral hemorrhage, hematoma, hemoptysis, muscle bleeding, gingival bleeding, pneumonia, sinusitis, visual disturbances, visual field defects, dry eyes, transient blindness, congestion, tinnitus, taste disorders, urinary disorders, polyuria, non-protein nitrogen increase, uremia, increased blood urea nitrogen, hypoglycemia, hyperuricemia, elevated liver enzymes, ALT elevation, abnormal liver function, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, bloating, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, postoperative wound bleeding, ocular hemorrhage, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, enteritis, pancreatitis, stomatitis, hepatitis, acute liver failure, petechial rash, erythematous skin rash, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulonephritis, gynecomastia, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air and moisture, ideally at a temperature between 1 degree and 30 degrees Celsius.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Clopidogrel Bisulfate
Prescription medication
Seas Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.